ANTENGENE CORP. DL-,0001ANTENGENE CORP. DL-,0001ANTENGENE CORP. DL-,0001

ANTENGENE CORP. DL-,0001

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪47.85 M‬EUR
−0.1110EUR
‪−74.49 M‬EUR
‪8.63 M‬EUR
‪460.77 M‬
Beta (1Y)
1.98

About ANTENGENE CORP LTD


CEO
Jian Ming Mei
Headquarters
Suzhou
Founded
2018
FIGI
BBG010JWLT55
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company, which engages in oncology medicines, R&D capabilities, and differentiated strategic approach to developing novel oncology therapies. It operates in the segments of the pharmaceutical, biotechnology and other related markets that address oncology diseases. The company was founded by Jian Ming Mei on August 28, 2018, and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ANTENGENE CORP. DL-,0001 stocks are traded under the ticker 722.
722 reached its all-time high on Jul 7, 2021 with the price of 2.1200 EUR, and its all-time low was 0.0100 EUR and was reached on May 7, 2021. View more price dynamics on 722 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ANTENGENE CORP. DL-,0001 financials in yearly and quarterly reports right on TradingView.
ANTENGENE CORP. DL-,0001 is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
722 earnings for the last half-year are −0.03 EUR per share, whereas the estimation was −0.04 EUR, resulting in a 20.59% surprise. The estimated earnings for the next half-year are −0.04 EUR per share. See more details about ANTENGENE CORP. DL-,0001 earnings.
ANTENGENE CORP. DL-,0001 revenue for the last half-year amounts to ‪7.81 M‬ EUR, despite the estimated figure of ‪7.71 M‬ EUR. In the next half-year revenue is expected to reach ‪4.55 M‬ EUR.
722 net income for the last half-year is ‪−21.63 M‬ EUR, while the previous report showed ‪−45.43 M‬ EUR of net income which accounts for 52.37% change. Track more ANTENGENE CORP. DL-,0001 financial stats to get the full picture.
No, 722 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 201.00 employees. See our rating of the largest employees — is ANTENGENE CORP. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANTENGENE CORP. DL-,0001 EBITDA is ‪−67.08 M‬ EUR, and current EBITDA margin is −982.81%. See more stats in ANTENGENE CORP. DL-,0001 financial statements.
Like other stocks, 722 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANTENGENE CORP. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.